MENU
XTNT
Stock ticker: ASE
PRICE
CHANGE
CAPITALIZATION

Xtant Medical Holdings (XTNT) Ownership - Who owns Xtant Medical Holdings?

Xtant Medical Holdings Inc is a medical technology company focused on the design, development, and commercialization of a comprehensive portfolio of orthobiologics and spinal implant systems to facilitate spinal fusion in complex spine, deformity and degenerative procedures... Show more

A.I.Advisor
Nov 16, 2026

What Is Xtant Medical Holdings (XTNT)? Company Overview, Business Model and Market Position

Key Takeaways

  • XTNT is the ticker for Xtant Medical Holdings, Inc., a U.S.-based medical technology company listed on the NYSE American exchange.
  • The company designs, develops, manufactures, and markets orthobiologics and spinal implant systems used in spinal fusion and other orthopedic and neurological procedures.
  • Xtant is headquartered in Belgrade, Montana, and was formerly known as Bacterin International Holdings, Inc.
  • Its business model combines a portfolio of regenerative biologics with spinal hardware, sold through a network of independent distributors, stocking agents, and group purchasing organizations.
  • Like many small-cap medical device makers, the company faces risks from reimbursement changes, competition, and the capital-intensive nature of its industry.

Introduction

Xtant Medical Holdings, Inc. is a medical technology company focused on surgical solutions for spinal and other orthopedic conditions. Investors follow XTNT because the company operates at the intersection of two large and growing healthcare markets: regenerative medicine (biologics that promote bone healing) and spinal implant hardware. Although it is a relatively small player compared with industry giants, Xtant has sought to differentiate itself through a vertically integrated biologics platform and a broad portfolio of products used by orthopedic spine surgeons and neurosurgeons.

Company Profile

Xtant Medical Holdings, Inc. traces its roots to a company formerly known as Bacterin International Holdings, Inc., and is incorporated in Delaware with its principal executive offices in Belgrade, Montana. Its common stock trades on the NYSE American exchange under the symbol XTNT.

The company develops, manufactures, and markets regenerative medicine products and medical devices for domestic and international markets. Its products serve the specialized needs of orthopedic and neurological surgeons, including orthobiologics for promoting bone healing, implants and instrumentation for treating spinal disease, and tissue grafts used in orthopedic, cranial, and foot and ankle procedures.

Core Products and Technologies

Xtant's orthobiologics portfolio includes products such as OsteoSponge (a natural scaffold for cellular in-growth), OsteoSelect DBM Putty (a moldable demineralized bone matrix, or DBM, which is processed human bone designed to support bone formation), 3Demin, OsteoFactor Pro, OsteoVive Plus, and the nanOss line of synthetic bone-graft substitutes. On the hardware side, the company offers spinal implant systems across cervical, thoracolumbar, sacroiliac joint, and interbody categories, along with related instrumentation.

Business Model and Revenue Sources

Xtant generates revenue primarily by selling its biologics and spinal implant products to hospitals, surgical centers, and surgeons. The company markets its products in the United States through an extensive network of independent commissioned agents and stocking distributors, supported by direct employees. It also maintains a national accounts program that provides access to integrated delivery networks (IDNs) and group purchasing organizations (GPOs), which negotiate supply contracts on behalf of hospitals and health systems. While the United States is its primary market, Xtant also sells internationally through distributors and direct representatives.

In recent years, Xtant has emphasized becoming a vertically integrated biologics manufacturer, producing its stem cell, growth factor, amniotic tissue, and synthetic biologics products in-house. This strategy is intended to improve supply-chain control, product quality, and gross margins.

Why Investors Follow XTNT

Investors pay attention to XTNT for several long-term reasons. The company operates in the spinal and orthopedic surgery market, which is supported by demographic trends such as an aging population and rising rates of degenerative spinal conditions. Within that space, orthobiologics represent a growth-oriented segment, as surgeons increasingly combine bone-graft materials with hardware to improve fusion outcomes.

Xtant's competitive positioning is built around its broad, vertically integrated biologics portfolio and its dual focus on biologics and spinal hardware, which allows it to offer complementary products across a single surgical procedure. The company has also pursued new product launches and strategic distribution agreements to expand its reach into adjacent markets, such as hemostatic (bleeding-control) products used in surgery.

Risks and Important Considerations

Investing in XTNT carries meaningful risks. As a small-cap medical device company, Xtant competes against larger, better-capitalized rivals with greater marketing resources and broader product lines. Its revenue can be sensitive to changes in government and private payer reimbursement policies, which affect how hospitals and surgeons purchase and use regenerative and implant products.

Operationally, the company's financial profile has historically been uneven, with periods of losses as it invests in new products and distribution. Customer and distribution-channel concentration, supply-chain dependencies, and regulatory requirements for tissue-based and medical device products are additional factors investors should understand. The company also periodically evaluates divestitures and strategic transactions, which can affect its product mix and financial results.

AI Screener

Tickeron's AI Screener is an AI-powered stock and ETF discovery platform that helps traders and investors identify opportunities using technical indicators, fundamentals, volatility, trends, AI-generated signals, industries, price patterns, and customizable filters. Users can efficiently screen thousands of stocks and ETFs to uncover ideas that align with their own investment strategies. Explore the AI Screener to refine your search for opportunities that match your criteria.

Conclusion

Xtant Medical Holdings, Inc. is a niche medical technology company that combines regenerative biologics with spinal implant systems to serve orthopedic and neurological surgeons. Its vertically integrated manufacturing approach, broad product portfolio, and presence in a large healthcare market give it a distinctive position among small-cap medical device companies. At the same time, its relatively small scale, exposure to reimbursement policy, and the competitive nature of the spine and orthobiologics industry are important considerations. For investors seeking exposure to the medical device and regenerative medicine sectors, XTNT offers a focused, though higher-risk, way to participate in that market.

Disclaimer

The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.

Disclaimers and Limitations

Profile

Industry
Medical Specialties
Address
664 Cruiser Lane
Phone
+1 406 388-0480
Employees
151
Web
http://www.xtantmedical.com

Details

Group
Domestic Stock Funds
Category
Health Services
Capitalization
40.6M
P/E Ratio
-3.62
Total Cash
9.87M
Projected Growth
N/A
Total Debt
26.01M
Revenue
109.53M
Risk (Beta)
0.55
Dividend Yield
N/A
Total Cash/Share
0.07
Total Debt/Equity
N/A
Revenue/Share
0.75 USD as % of share price
Who owns Xtant Medical Holdings? XTNT symbol Ownership - Tickeron.com